UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10QSB

 -------- ---------------------------------------------------------------------
 [X]      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
          Exchange Act of 1934
          FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 2004
 -------- ---------------------------------------------------------------------
          OR
 -------- ---------------------------------------------------------------------
 [ ]      Transition Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934
 -------- ---------------------------------------------------------------------
          For the transition period from to
 -------- ---------------------------------------------------------------------

                         COMMISSION FILE NUMBER: 0-30351

                                True Health, Inc.
             (Exact name of registrant as specified in its charter)

-------------------------------------------- ----------------------------------
           Utah                                               75-2263732
-------------------------------------------- ----------------------------------
(State of other jurisdiction                       (IRS Employer Identification
of incorporation or organization)                  Number)
--------------------------------------------- ---------------------------------

                          Kelsey House, 77 High Street
                                 Beckenham, Kent
                                   UK BR3 1AN
                    (Address of principal executive offices)

                             +(44) (0) 208 658 9575
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
                           Yes [ x ]        No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of October 31, 2004:      51,616,875




                                TRUE HEALTH, INC.
                           CONSOLIDATED BALANCE SHEET
                                October 31, 2004
                                   (unaudited)
<TABLE>

ASSETS
<S>                                                                                          <C>
Current Assets
  Cash                                                                                        $    32,899
  Accounts receivable, net                                                                        676,935
  Inventory                                                                                       206,900
  Other                                                                                            67,338
                                                                                              -----------

         Total Current Assets                                                                     984,072
                                                                                              -----------

Equipment, net of accumulated depreciation                                                        250,426
                                                                                              -----------

TOTAL ASSETS                                                                                  $ 1,234,498
                                                                                              ===========


LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
  Note payable to factor                                                                      $   313,196
  Current portion of notes payable                                                                182,983
  Accounts payable                                                                                131,319
  Accrued expenses                                                                                372,218
  Accounts payable to stockholder                                                                 122,430
                                                                                              -----------

         Total Current Liabilities                                                              1,122,146
                                                                                              -----------

Long-term portion of notes payable                                                                140,557
                                                                                               -----------

         Total Liabilities                                                                      1,262,703
                                                                                              -----------

Stockholders' Equity
  Common stock, $.01 par value; 100,000,000 shares
  authorized; 51,616,875 shares issued and outstanding                                            516,169
  Additional paid in capital                                                                    1,654,587
  Accumulated deficit                                                                          (2,184,464)
  Accumulated other comprehensive loss                                                            (14,497)
                                                                                              -----------

  Total Stockholders' Equity                                                                       (28,205)
                                                                                              -----------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                    $ 1,234,498
                                                                                              ===========


</TABLE>


                                TRUE HEALTH, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
          Three Months and Nine Months Ended October 31, 2004 and 2003
                                   (unaudited)


<TABLE>


                                                        Three Months Ended                  Nine Months Ended
                                                       2004            2003             2004             2003
                                                   ----------       ----------        ----------      ----------
<S>                                               <C>               <C>             <C>               <C>
Revenue
- Equipment rentals and sales                     $  452,451        $  350,423       $ 1,459,228      $  948,073
- Recruitment services
     and placement fees                              872,489           935,737         3,119,230         1,751,299
- Other                                                9,447            16,776            30,210            33,372
                                                  ----------        ----------        ----------      ----------

Total Revenues                                     1,334,387         1,302,936         4,608,668         2,732,744
Cost of sales                                        881,741           789,909         2,976,484         1,570,441
                                                  ----------        ----------        ----------      ----------

Gross margin                                          452,646          513,027         1,632,184         1,162,303
                                                  ----------        ----------        ----------      ----------

General and administrative
- Non-cash professional fees                               0                 0           600,000         499,448
- Other                                              546,522           514,414         1,951,862         1,286,489
Depreciation                                          29,525            27,925            90,763            86,098
                                                  ----------        ----------        ----------      ----------

  Total operating expenses                           576,047           542,339         2,642,625         1,872,035
                                                  ----------        ----------        ----------      ----------

Net Operating Loss                                  (123,401)          (29,312)       (1,010,441)         (709,732)

Interest income                                          318                 0               318                19
Interest expense                                     (10,753)           (11,617)          (34,916)          (49,689)
                                                  ----------        ----------        ----------      ----------

Net loss before taxes                               (133,836)           (40,929)       (1,045,040)         (759,402)

Income tax expense                                         0                  0                 0                 0
                                                  ----------        ----------        ----------      ----------

Net Loss                                           $ (133,836)      $  (40,929)      $ (1,045,040)     $ (759,402)
                                                  ==========        ==========        ==========      ==========

Basic and diluted loss
     per share                                    $    (0.00)          $    (0.00)       $    (0.02)$    (0.01)

Weighted average shares
     outstanding                                   51,558,179             40,889,292        50,974,236  39,194,646


</TABLE>






                                TRUE HEALTH, INC.
                      STATEMENTS OF CONSOLIDATED CASH FLOW
                   Nine Months Ended October 31, 2004 and 2003
                                   (unaudited)
<TABLE>
                                                                                   2004                  2003
                                                                                  ----------             ---------
<S>                                                                              <C>                     <C>
Cash Flows From Operating Activities
  Net loss                                                                       $(1,045,040)            $(759,402)
  Adjustments to reconcile net loss to net cash
    used in operating activities:
    Depreciation                                                                      99,314                86,098
    Stock issued for services                                                        600,000               469,758
    Stock warrants issued for services                                                     -                57,144
    Imputed interest on shareholder notes payable                                      7,203                22,848
    Changes in:
         Accounts receivable                                                          19,882              (605,496)
         Inventory                                                                  (101,991)                6,876
         Other current assets                                                          5,162               (24,188)
         Accounts payable                                                             12,294                25,376
         Accrued expenses                                                            115,090               156,571
                                                                                   ---------             ---------

  Net Cash Used in Operating Activities                                             (288,086)             (564,415)
                                                                                   ---------             ---------
Cash Flows Used in Investing Activities
  Purchase of equipment                                                             (104,284)             (63,503)
                                                                                   ---------             ---------
Cash Flows From Financing Activities
  Proceeds from exercise of warrants for stock                                       475,000               336,307
  Proceeds from issue of common stock                                                 64,500                     0
  Net change in note payable to factor                                              (82,544)               438,219
  Net change in note payable to notes payable                                       (145,522)              (49,960)
  Net change in note payable to related party                                       (165,930)                    0
                                                                                   ---------             ---------

  Net Cash Provided By Financing Activities                                          145,504               724,566
                                                                                  ---------               ---------

Currency translation adjustment                                                       23,119               (45,337)
                                                                                   ---------             ---------

Net change in cash                                                                  (223,747)               51,311
Cash at beginning of period                                                          256,646                   255
                                                                                   ---------             ---------

Cash at end of period                                                              $  32,899            $   51,566
                                                                                   =========             =========
</TABLE>




                                 TRUE HEALTH INC
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)


NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited interim financial statements of True Health Inc.
(True Health) have been prepared in accordance with accounting principles
generally accepted in the United States of America and the rules of the
Securities and Exchange Commission ("SEC"), and should be read in conjunction
with the audited financial statements and notes thereto contained in True
Health, Inc.'s Annual Financial Statements filed with the SEC on Form 10-K and
in respect of the comparative period, the significant acquisition statement
filed with the SEC on Form 8-K. In the opinion of management, all adjustments,
consisting of normal recurring adjustments, necessary for a fair presentation of
financial position and the results of operations for the interim periods
presented have been reflected herein. The results of operations for interim
periods are not necessarily indicative of the results to be expected for the
full year. Notes to the financial statements which would substantially duplicate
the disclosure contained in the audited financial statements for the most recent
fiscal year ended to January,31 2004, as reported in the Form 10-KSB, have been
omitted.

NOTE 2 - COMMON STOCK

During the nine months ended October 31, 2004, 1,000,000 shares valued at
$600,000 were issued to consultants for services in 2004.

During the quarter ended October 31, 2004, 200,000 shares were sold to investors
for $64,500, in return for a cash subscription.

During the quarter ended April 30, 2004, warrants for 718,545 shares were
exercised for cash proceeds of $475,000.

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Important Information Regarding Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Those statements
include indications regarding our intent, belief or current expectations,
including our plans with respect to the sourcing, manufacturing, marketing and
distribution of our products and services, the belief that current levels of
cash and cash equivalents together with cash from operations and existing credit
facilities will be sufficient to meet its working capital requirements for the
next twelve months, our expectations with respect to the performance of the
counterparties to its letter of credit agreements, our plans to invest in
derivative instruments and the collection of accounts receivable, our beliefs
and intent with respect to and the effect of changes in financial accounting
rules on its financial statements. Such statements are subject to a variety of
risks and uncertainties, many of which are beyond the our control, which could
cause actual results to differ materially from those contemplated in such
forward-looking statements, which include, among other things, (i) changes in
the marketplace for our products and services, (ii) the introduction of new
products or pricing changes by our competitors, (iii) changes in exchange rates,
and (iv) changes in the economy. Existing and prospective investors are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date hereof. We undertake no obligation to update or revise
the information contained in this Quarterly Report on Form 10-QSB, whether as a
result of new information, future events or circumstances or otherwise.

Critical accounting policies

We have identified the policies below as critical to our business operations and
the understanding of our results of operations. The impact and any associated
risks related to these policies on our business operations is discussed
throughout Management's Discussion and Analysis of Financial Condition and
Results of Operations where such policies affect our reported and expected
financial results. The preparation of this Quarterly Report on Form 10-QSB
requires us to make estimates and assumptions that affect the reported amount of
assets and liabilities, disclosure of contingent assets and liabilities at the
date of our financial statements, and the reported amounts of revenue and
expenses during the reporting period. There can be no assurance that actual
results will not differ from those estimates.

1) Allowance for doubtful accounts

We evaluate the adequacy of the allowance for doubtful accounts at the end of
each quarter. In performing this evaluation, we analyze the payment history of
significant past due accounts, subsequent cash collections on these accounts and
comparative accounts receivable aging statistics. Based on this information,
along with consideration of the general strength of the economy, we develop what
we consider to be a reasonable estimate of the uncollectible amounts included in
accounts receivable. This estimate involves our significant judgment. Actual
uncollectible amounts may differ from our estimate.

2) Provision for obsolete inventory

We estimate our provision for obsolete inventory based on customer orders sold
below cost, to be shipped in the following period and on the amount of similar
unsold inventory at period end. We analyze recent sales and gross margins on
unsold inventory in further estimating the inventory provision. The impact of
the inventory provision is reflected in cost of sales and the related gross
margins in the period that management deems that inventory has become obsolete.
This estimate involves our significant judgment. Actual gross margins on sales
of excess inventory may differ from our estimate.

Three Months Ended October 31, 2004 Compared to Three Months Ended October 31,
2003

Revenue

Total revenue for the three months ended October 31, 2004 was $1,334,387. This
represents an increase of $31,451 or 2.4%, when compared to revenue of
$1,302,936 for the three months ended October 31, 2003.

Revenue from the equipment rentals and sales segment increased by $102,028, or
29.1%, to $452,451 in the three months ended October 31, 2004 compared to
$350,423 in the three months ended October 31, 2003. This increase reflects the
continued growth in the equipment business over the past year. This mainly arose
from an increase in the customer base and through our geographic expansion via
our Distributor Network.

Revenue from recruitment services and the placement of medical staff, including
radiographers, social workers and nurses was $872,489 for the three months ended
October 31, 2004. This represents a decrease of $63,248, or 6.8%, when compared
with revenues for the same period last year of $935,737.


Cost of sales

Cost of sales for the three months ended October 31, 2004, compared to the three
months ended October 31, 2003 are shown below:

<TABLE>
                                               Three months ended          Three months ended
                                                 October 31, 2004            October 31, 2003
<S>                                            <C>                         <C>
Equipment rentals and sales                        $172,790  12.9%            $ 51,741  3.97%

Recruitment services and                            708,951  53.2%            $738,168  56.7%
- placement fees

Total                                            $  881,741  66.1%             $789,909  60.6%

</TABLE>
The total Gross Profit of $452,646 decreased by $60,381, when compared with the
gross profit of $513,027 in the three months ended October 31, 2003. This
represents a reduction in total gross profits of 11.8%.


General and administrative overheads

Total operating expenses amounted to $576,047 compared to $542,339 for the three
months to October 31, 2003. Of this, general and administrative overheads for
the three months to October 31, 2004 rose to $546,522, compared with $514,414
for the same period last year. Although the increase in expenses of $32,108
represents growth of 6.2% on this time last year, there are some shifts of
emphasis on areas of expenditure.

The reasons for this increase in expenditure are mainly due to:

o        An increase in the employment of experienced staff and senior personnel
         in order to support the expansion of business on a more sustainable
         basis
o        An increase in other office related costs reflecting the increase in
         staff.
o        Costs associated with a project to implement a new integrated operating
         and financial IT software system. Much of the work relating to the
         project scoping, data testing and process reviews had been undertaken
         during the third quarter of 2004, prior to the project going live in
         November.
o        The write off of $64,636 relating to the provision for obsolete
         inventories, following the detailed work undertaken during the above
         project.

Interest expense

Net Interest expense of $10,435 for the three months ended October 31, 2004, is
compared with $11,617 for the three months ended October 31, 2003.


Liquidity and Capital Resources

We have relied primarily on asset-based borrowings, internally generated funds,
stockholder investment and loans, together with trade credit to finance our
operations. Our capital requirements primarily result from working capital
needed to support operations, including increases in inventory and funding
accounts receivable. Our working capital position has deteriorated from a
deficit of $255,335 as of January 31, 2004 to a deficit of $138,074 as of
October 31, 2004. This compares to a deficit of $76,857 as at July 31, 2004.

As of October 31, 2004, we had cash and cash equivalents of $32,899 compared to
$51,566 as of October 31, 2003. The ability of the Company to continue as a
going concern, in terms of paying its creditors as they fall due, is dependant
upon the continued support of our bankers, and principle shareholder, in
addition to raising further funds from external shareholders.


Operating Cash Flow

Net cash used in operating activities for the nine months ended October 31, 2004
was $288,086 compared with net cash used of $564,415 for the nine months ended
October 31, 2003. This is primarily due to the loss for the period, and the rise
in inventories in order to meet future orders.

Credit Facilities

We have a loan agreement with bankers, HSBC, for a term loan that advanced
$237,000 in January 2003 and is due for repayment by November 2007. The loan
attracts a variable rate interest of 2% over UK base rate and there is a
floating charge over the assets of the Company (6.75% at October 31, 2004).

We also have an accounts receivable factoring arrangement with Venture Finance,
which is secured by a floating charge over our assets. This facility has
attracts variable rate interest of 1.75% over UK base rate (6.5% at October 31,
2004).

We believe that current levels of cash and cash equivalents ($32,899 at October
31, 2004) together with cash from operations and funds available under our
existing credit facilities and additional funding exercises, will be sufficient
to meet our capital requirements for the next twelve months.


Nine Months Ended October 31, 2004 Compared to Nine Months Ended October 31,
2003

Revenue

Total revenue for the nine months ended October 31, 2004 was $4,608,668
representing an increase of $1,875,924 or 68.6%, when compared to revenue of
$2,732,744 for the nine months ended October 31, 2003.

Revenue from the equipment rentals and sales segment of $1,459,228 increased by
$511,155, or 53.9%, in the nine months ended October 31, 2004, compared to
$948,073 for the nine months ended October 31, 2003. This increase reflects the
growth in the business over the past year, which mainly arose from an increase
in the customer base and through our geographic expansion via our Distributor
Network.

Revenue from the recruitment services and placement segment increased by
$1,367,931 to $3,119,230 for the nine months ended October 31, 2004. This
represents a 78.1% increase on the recruitment revenue of $1,751,299 for the
nine months to October 31, 2003.

Cost of sales

Cost of sales for the nine months ended October 31, 2004, compared to the nine
months ended October 31, 2003 are as follows:

<TABLE>
                                              Nine months ended             Nine months ended
                                               October 31, 2004              October 31, 2003
<S>                                           <C>                           <C>
Equipment rentals and sales                    $  424,458  9.2%               $236,541  8.7%

Recruitment services and                        2,552,026  55.4%               1,333,900  48.8%
 - placement fees

Total                                          $2,976,484  64.6%               $1,570,441 57.5%

</TABLE>
The total Gross Profit for the nine months to October 31, 2004, of $1,632,184
represents an increase of $469,881 (40.4%) on the gross profit of $1,162,303
generated in the nine months ended October 31, 2003.

General and administrative overheads

General and administrative overhead expenditure increased by $770,590, or 41.2%
to $2,642,625 for the nine months to October 31, 2004, compared with overhead
expenditure of $1,872,035 for the nine months to October 31, 2003. The main
reasons for the increase in expenditure are as for the items outlined in the
management discussion and analysis section for the three months results. In
addition to these we experienced:

o        An increase in the number of sales employees and support staff,
         reflecting the increase in revenues.

o        An increase in consultancy costs, for which shares were issued in
         compensation to $600,000 in the period, compared with
         similar period last year of $499,448.

Interest expense

Net Interest expense of $34,599 for the nine months to October 31, 2004, has
reduced by $15,071, or 30.3%, compared with $49,670 for the nine months to
October 31, 2003. This improvement has been mainly due to the improved cash
position during much of the last year arising from investment from warrant
holders.


ITEM 3. CONTROLS AND PROCEDURES

At October 31, 2004, we carried out an evaluation, under the supervision and
with the participation of our management, including our Chief Executive Officer
and Chief Financial Officer, of the effectiveness of the design and operation of
our disclosure controls and procedures pursuant to Rule 13a-14 under the
Securities Exchange Act of 1934, as amended.

During the quarter ended October 31, 2004 we undertook a project to upgrade our
accounting and operating software systems in order to improve operational
efficiency and internal reporting. This allowed us to further improve our
existing processes and procedures relating to the processing of equipment orders
and the control and reporting of inventories generally. The additional detailed
work undertaken during this project identified some areas for improvement in the
control, tracking and reporting of inventories, for which the upgrade software,
which integrates the equipment operating system and financial systems, would
provide. This project went live in November and management are confident in the
functionality of the new system to provide increased levels of control and
operational efficiency. Other than in the above area there have been no
significant changes in our internal controls or in other factors that could
significantly affect our controls subsequent to the date of that evaluation, and
no corrective actions with regard to significant deficiencies and material
weaknesses.

Based upon that evaluation, the Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures are effective in
timely alerting them to material information relating to the Company required to
be included in our periodic SEC filings.


                           PART II - OTHER INFORMATION



ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits          Item Description
     31.1       Certification Pursuant to Section 302 of the
                           Sarbanes-Oxley Act of 2002
     31.2       Certification Pursuant to Section 302 of the
                           Sarbanes-Oxley Act of 2002
     32         Certification Pursuant to 18 U.S.C. Section 1350, as
                           Adopted Pursuant to Section 906 of the
                           Sarbanes-Oxley Act of 2002


(b) Report on Form 10-KSB

On May 17, 2004, we filed a report on Form 10-KSB relating to our results for
the year ended January 31, 2004.


(c) Report on Form 10-QSB

On June 15, 2004, we filed a report on Form 10-QSB relating to our results for
the quarter ended April 30, 2004.

(d) Report on Form 10-QSB

On September 20, 2004, we filed a report on Form 10-QSB relating to our results
for the quarter ended July 31, 2004.

(e) Report on Form 8-K

On December 12, 2004, we filed a report on Form 8-K relating to the resignation
of officers of the company.


                                                     SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

         Dated:  December 22, 2004.

                                               TRUE HEALTH, INC.

                                               BY: David Francis
                                                  -------------------
                                                  David Francis, CEO



                                               BY: Ian Wylie
                                                   ------------------
                                                   Ian Wylie, CFO




                                  Exhibit 31.1

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, David Francis, certify that:

1.       I have reviewed the quarterly report on Form 10-QSB of True Health,
         Inc. for the period ended October 31, 2004 (this "Report");


2.          Based on my knowledge, this Report does not contain any untrue
            statement of a material fact or omit to state a material fact
            necessary to make the statements made, in light of the circumstances
            under which such statements were made, not misleading with respect
            to the period covered by this Report;


3.          Based on my knowledge, the financial statements, and other financial
            information included in this Report, fairly present in all material
            respects the financial condition, results of operations and cash
            flows of the registrant as of, and for, the periods presented in
            this Report;


4.          The registrant's other certifying officers and I are responsible for
            establishing and maintaining disclosure controls and procedures (as
            defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant
            and we have:

(a)         designed such disclosure controls and procedures to ensure that
            material information relating to the registrant, including its
            consolidated subsidiaries, is made known to us by others within
            those entities, particularly during the period in which this Report
            is being prepared;

(b)         evaluated the effectiveness of the registrant's disclosure controls
            and procedures as of a date within 90 days prior to the
            filing date of this Report (the "Evaluation Date"); and


(c)         presented in this Report our conclusions about the effectiveness of
            the disclosure controls and procedures based on our evaluation as of
            the Evaluation Date;

5.   The registrant's other certifying officers and I have disclosed, based
     on our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors:

(a)           all significant deficiencies in the design or operation of
              internal controls which could adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and

(b)           any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and

6.   The registrant's other certifying officers and I have indicated in this
     Report whether or not there were significant changes in internal controls
     or in other factors that could significantly affect internal controls
     subsequent to the date of our most recent evaluation, including any
     corrective actions with regard to significant deficiencies and material
     weaknesses.

Dated: December 22, 2004


David Francis
--------------------------------------
David Francis, CEO


                                  Exhibit 31.2

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, Ian Wylie, certify that:

7.     I have reviewed the quarterly report on Form 10-QSB of True Health, Inc.
       for the period ended October 31, 2004 (this "Report");

8.     Based on my knowledge, this Report does not contain any untrue statement
       of a material fact or omit to state a material fact necessary to make the
       statements made, in light of the circumstances under which such
       statements were made, not misleading with respect to the period covered
       by this Report;

9.     Based on my knowledge, the financial statements, and other financial
       information included in this Report, fairly present in all material
       respects the financial condition, results of operations and cash flows of
       the registrant as of, and for, the periods presented in this Report;

10.    The registrant's other certifying officers and I are responsible for
       establishing and maintaining disclosure controls and procedures (as
       defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
       we have:

       (d)    designed such disclosure controls and procedures to ensure that
              material information relating to the registrant, including its
              consolidated subsidiaries, is made known to us by others within
              those entities, particularly during the period in which this
              Report is being prepared;
       (e)    evaluated the effectiveness of the registrant's disclosure
              controls and procedures as of a date within 90 days prior to the
              filing date of this Report (the "Evaluation Date"); and
       (f)    presented in this Report our conclusions about the effectiveness
              of the disclosure controls and procedures based on our evaluation
              as of the Evaluation Date;

11.    The registrant's other certifying officers and I have disclosed, based on
       our most recent evaluation, to the registrant's auditors and the audit
       committee of registrant's board of directors: (c) all significant
       deficiencies in the design or operation of internal controls which could
       adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
       (d)    any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and

12.    The registrant's other certifying officers and I have indicated in this
       Report whether or not there were significant changes in internal controls
       or in other factors that could significantly affect internal controls
       subsequent to the date of our most recent evaluation, including any
       corrective actions with regard to significant deficiencies and material
       weaknesses.


Dated: December 22, 2004


Ian Wylie
--------------------------------------
Ian Wylie, CFO



                                   Exhibit 32

         Certification Pursuant to 18U.S.C Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

Each   of the undersigned hereby certifies, for the purposes of section 1350 of
       chapter 63 of title 18 of the United States Code, in his capacity as an
       officer of True Health, Inc. ("True Health"), that, to his knowledge, the
       quarterly report on Form 10-QSB of True Health, Inc. for the period ended
       October 31, 2004, fully complies with the requirements of Section 13(a)
       of the Securities Exchange Act of 1934 and that the information contained
       in such amendment to said report fairly presents, in all material
       respects, the financial condition and results of operation of True
       Health.

Dated: December 22, 2004




David Francis
--------------------------------------
David Francis, CEO




Ian Wylie
--------------------------------------
Ian Wylie, CFO